David M. Smadja

Summary

David M. Smadja is a human^[1]. He was born on January 1, 1978^[2]. He worked as a researcher^[3] and hematologist^[4]. He ranks in the top 0.73% of human entities by monthly Wikipedia readership (97 views/month, #7,300 of 1,000,298).^[5]

Key Facts

• David M. Smadja was born on January 1, 1978^[2].
• David M. Smadja held citizenship in France^[6].
• David M. Smadja worked as a researcher^[3].
• David M. Smadja's professions included hematologist^[4].
• David M. Smadja was employed by Paris Descartes University^[7].
• David M. Smadja was employed by Georges Pompidou European Hospital^[8].
• Among David M. Smadja's employers was Broussais hospital^[9].
• David M. Smadja's doctoral advisor was Pascale Gaussem^[10].
• A notable work attributed to David M. Smadja is PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system^[11].
• David M. Smadja is recorded as male^[12].
• David M. Smadja's instance of is recorded as human^[13].
• David M. Smadja supervised Laetitia Mauge as a doctoral student^[14].
• David M. Smadja's family name is recorded as Smadja^[15].
• David M. Smadja's given name is recorded as David^[16].
• David M. Smadja's on focus list of Wikimedia project is recorded as WikiProject COVID-19^[17].

Body

Origins and Family

David M. Smadja was born on January 1, 1978^[2].

Education

David M. Smadja's doctoral advisor was Pascale Gaussem^[10].

Career and Affiliations

Recorded occupations include researcher^[3] and hematologist^[4]. Employers include Paris Descartes University^[7], a public research university^[18], in France^[19], founded in 1971^[20], headquartered in Paris^[21]; Georges Pompidou European Hospital^[8], a facility^[22], in France^[23], founded in 2001^[24]; and Broussais hospital^[9], a private mansion^[25], in France^[26]. David M. Smadja supervised Laetitia Mauge as a doctoral student^[14].

Works and Contributions

A notable work attributed to David M. Smadja is PAR-1 activation on human late endothelial progenitor cells enhances angiogenesis in vitro with upregulation of the SDF-1/CXCR4 system^[11].

Why It Matters

David M. Smadja ranks in the top 0.73% of human entities by monthly Wikipedia readership (97 views/month, #7,300 of 1,000,298).^[5] He is known by 3 alternative names across languages and contexts.^[27]

FAQs

What did David M. Smadja do for work?

David M. Smadja worked as researcher^[3] and hematologist^[4].